Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Completed 32Unknown 31Recruiting 26Not yet recruiting 15Terminated 8Active not recruiting 4Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 5INDUSTRY 3

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Breast 8

Conditions

Breast Neoplasms 1127Neoplasms 982Carcinoma, Non-Small-Cell Lung 900Prostatic Neoplasms 594Neoplasm Metastasis 528Leukemia, Myeloid, Acute 513Colorectal Neoplasms 491Lung Neoplasms 487Melanoma 485Multiple Myeloma 477Pancreatic Neoplasms 385Lymphoma 369Ovarian Neoplasms 368Recurrence 365Lymphoma, Non-Hodgkin 346Leukemia 339Leukemia, Lymphocytic, Chronic, B-Cell 321Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Head and Neck Neoplasms 276Carcinoma, Renal Cell 276Brain Neoplasms 273Carcinoma, Hepatocellular 261Glioblastoma 249Lymphoma, Large B-Cell, Diffuse 244Myelodysplastic Syndromes 242Squamous Cell Carcinoma of Head and Neck 241Lymphoma, Follicular 236Colonic Neoplasms 214Stomach Neoplasms 200Rectal Neoplasms 190

Interventions

Letrozole 2Goserelin 2Fulvestrant 2olaparib 1abemaciclib 1Trastuzumab 1Lead 1Aromatase Inhibitors 1Anastrozole 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Terminated × Advanced Breast Cancer × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

NCT04227327 2025-07-29

HERMIONE-7

University of Milano Bicocca

Phase 2 Terminated
31 enrolled
Breast

Advanced Breast Cancer

NCT04862143 2024-06-20

TELEPIK

Novartis

Phase 2 Terminated
2 enrolled 10 charts
Breast

Advanced Breast Cancer

NCT04655573 2024-05-16

A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer

Duke University

Terminated
7 enrolled
Breast

Advanced Breast Cancer

NCT04714619 2023-12-19

CAILA

MedSIR

Phase 2 Terminated
2 enrolled
Breast

Advanced Breast Cancer

NCT03931551 2023-02-22

OPHELIA

MedSIR

Phase 2 Terminated
5 enrolled
Breast

Advanced Breast Cancer

NCT02054338 2019-08-28

VICTORIA

Pierre Fabre Medicament

Phase 3 Terminated
1,004 enrolled 11 charts
Breast

Advanced Breast Cancer

NCT01836640 2016-08-16

Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer

Dartmouth-Hitchcock Medical Center

Terminated
9 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡